Lih‐Ching Hsu

1.7k total citations
62 papers, 1.4k citations indexed

About

Lih‐Ching Hsu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lih‐Ching Hsu has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 20 papers in Oncology and 14 papers in Genetics. Recurrent topics in Lih‐Ching Hsu's work include Microtubule and mitosis dynamics (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and DNA Repair Mechanisms (7 papers). Lih‐Ching Hsu is often cited by papers focused on Microtubule and mitosis dynamics (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and DNA Repair Mechanisms (7 papers). Lih‐Ching Hsu collaborates with scholars based in Taiwan, United States and Italy. Lih‐Ching Hsu's co-authors include R. White, Jih‐Hwa Guh, Jui‐Ling Hsu, Julie A. DeLoia, Michael N. Gould, Wei‐Ling Chang, Ching‐Shih Chen, Susanne M. Gollin, Yunn‐Fang Ho and Xin Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.

In The Last Decade

Lih‐Ching Hsu

61 papers receiving 1.4k citations

Peers

Lih‐Ching Hsu
Lih‐Ching Hsu
Citations per year, relative to Lih‐Ching Hsu Lih‐Ching Hsu (= 1×) peers Claudia Götz

Countries citing papers authored by Lih‐Ching Hsu

Since Specialization
Citations

This map shows the geographic impact of Lih‐Ching Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lih‐Ching Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lih‐Ching Hsu more than expected).

Fields of papers citing papers by Lih‐Ching Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lih‐Ching Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lih‐Ching Hsu. The network helps show where Lih‐Ching Hsu may publish in the future.

Co-authorship network of co-authors of Lih‐Ching Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Lih‐Ching Hsu. A scholar is included among the top collaborators of Lih‐Ching Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lih‐Ching Hsu. Lih‐Ching Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hsu, Jui‐Ling, She‐Hung Chan, Lih‐Ching Hsu, et al.. (2024). A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer. The Prostate. 84(6). 605–619. 2 indexed citations
4.
Kung, Fan‐Lu, et al.. (2024). Sensitization of cancer cells to paclitaxel-induced apoptosis by canagliflozin. Biochemical Pharmacology. 223. 116140–116140. 9 indexed citations
5.
Hsu, Ya-Fen, Fan‐Lu Kung, Jih‐Hwa Guh, et al.. (2023). Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells. Molecules. 28(5). 2358–2358. 3 indexed citations
6.
Li, Yuliang, et al.. (2019). The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells. Frontiers in Pharmacology. 10. 1311–1311. 37 indexed citations
8.
Chen, Guan‐Yuan, Lih‐Ching Hsu, Hsiao‐Wei Liao, et al.. (2017). Using precursor ion scan of 184 with liquid chromatography-electrospray ionization-tandem mass spectrometry for concentration normalization in cellular lipidomic studies. Analytica Chimica Acta. 971. 68–77. 23 indexed citations
9.
Marchetti, Paolo, Barbara Pavan, Daniele Simoni, et al.. (2016). A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach. European Journal of Pharmaceutical Sciences. 91. 50–63. 8 indexed citations
10.
Baruchello, Riccardo, Riccardo Rondanin, Paolo Marchetti, et al.. (2016). Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth. Biochemical Pharmacology. 113. 12–23. 7 indexed citations
13.
Chang, Hung‐Chi, et al.. (2013). Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG. Molecular BioSystems. 9(8). 2010–2020. 20 indexed citations
15.
16.
Yu, Young‐Mi, et al.. (2008). A PP1-binding motif present in BRCA1 plays a role in its DNA repair function. International Journal of Biological Sciences. 4(6). 352–361. 22 indexed citations
18.
Hsu, Lih‐Ching, et al.. (2006). Gene amplification and overexpression of protein phosphatase 1α in oral squamous cell carcinoma cell lines. Oncogene. 25(40). 5517–5526. 35 indexed citations
19.
Hsu, Lih‐Ching, Ray M. Lee, & R. White. (2004). The HPV16 E6/E7 oncogene sensitizes human ovarian surface epithelial cells to low-dose but not high-dose 5-FU and 5-FUdR. Biochemical and Biophysical Research Communications. 320(1). 249–255. 3 indexed citations
20.
Hsu, Lih‐Ching & Michael N. Gould. (1991). Molecular cloning of Copenhagen rat Krev-1 and rap1B cDNAs and study of their association with mammary tumor resistance in the Copenhagen rat. Carcinogenesis. 12(3). 533–536. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026